Time-to-treatment failure (TTF) with first-line afatinib...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Time-to-treatment failure (TTF) with first-line afatinib (A) vs gefitinib (G) in patients (pts) with EGFR mutation-positive (EGFRm+) advanced non-small-cell lung cancer (NSCLC): Randomized phase IIb LUX-lung 7 (LL7) trial

Schuler, M., Tan, E-H., O'Byrne, K., Zhang, L., Boyer, M., Mok, T.S.K., Hirsh, V., Yang, J.C-H., Lee, K.H., Lu, S., Shi, Y., Kim, S-W., Laskin, J., Kim, D-W., Arvis, C. Dubos, Kölbeck, K., Massey, D.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw383.30
Date:
October, 2016
File:
PDF, 43 KB
english, 2016
Conversion to is in progress
Conversion to is failed